Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899158 · ClinicalTrials.gov registry record
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 44
- Enrollment target
NCT00899158 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 44 participants.
The verdict
NCT00899158 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
RATIONALE: Learning about biological markers in patients with pancreatic cancer and cachexia may help doctors predict patient outcome and may help the study of cancer in the future. PURPOSE: This laboratory study is examining biological markers in patients with pancreatic cancer experiencing weight loss.
Interventions
- OTHER laboratory biomarker analysis
- PROCEDURE biopsy
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899158
The ClinicalTrials.gov registry entry for NCT00899158 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00899158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00899158 about?
NCT00899158 is a clinical study titled "Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss". RATIONALE: Learning about biological markers in patients with pancreatic cancer and cachexia may help doctors predict patient outcome and may help the study of cancer in the future. PURPOSE: This laboratory study is examining biological markers in patients with pancreatic cancer experiencing weight...
What is the current status of trial NCT00899158?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2005-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00899158?
The interventions under investigation include: laboratory biomarker analysis (OTHER), biopsy (PROCEDURE), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00899158?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.